Overlapping B cell pathways in severe COVID-19 and lupus
Open Access
- 2 November 2020
- journal article
- editorial
- Published by Springer Nature in Nature Immunology
- Vol. 21 (12) , 1478-1480
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19Nature Immunology, 2020
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19Cell, 2020
- A dynamic COVID-19 immune signature includes associations with poor prognosisNature Medicine, 2020
- Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Hospitalization and Mortality among Black Patients and White Patients with Covid-19New England Journal of Medicine, 2020
- Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severityHuman Molecular Genetics, 2020
- IL-10 producing regulatory and helper T-cells in systemic lupus erythematosusSeminars in Immunology, 2019
- Extrafollicular responses in humans and SLEImmunological Reviews, 2019
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus ErythematosusImmunity, 2018
- Interleukin‐6 Deficiency Corrects Nephritis, Lymphocyte Abnormalities, and Secondary Sjögren's Syndrome Features in Lupus‐Prone Sle1.Yaa MiceArthritis & Rheumatology, 2014